Navigation Links
Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/6/2008

ase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment using Haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes.

Synvista Therapeutics also is developing alagebrium, a proposed breaker of AGEs for the treatment of diastolic heart failure. This disease represents a rapidly growing market of unmet medical need, particularly common among diabetic patients. Alagebrium has demonstrated relevant clinical activity in two Phase 2 clinical trials in heart failure, as well as in animal models of heart failure and nephropathy, among others. Alagebrium has been tested in approximately 1,000 patients in multiple Phase 1 and Phase 2 clinical trials, allowing Synvista Therapeutics to assemble a sizeable human safety database. For more information, please visit the Company's website at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future clinical development of Synvista Therapeutics' product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2006. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual result
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
6. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
7. Echo Therapeutics to Present at RedChip Small-Cap Investor Conference
8. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
9. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
10. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
11. Taligen Therapeutics Secures Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... at USC have developed a new microscopy technology ... living animals at higher-than-ever resolution. , Dubbed "Complementation ... imaging resolutions that are an order of magnitude ... into the behavior of biomolecules at the nanometer ... 18 by Nature Communications , the researchers ...
(Date:9/18/2014)... quest for the ultimate memory device for computing may ... The City College of New York led by chemist ... both magnetic and ferroelectric properties. , Combining both properties ... occur between them and for the devices that might ... these two properties in a single material, however, has ...
(Date:9/18/2014)... 18, 2014 Pipette.com announces brand ... Socorex, Capp, and AccuPet brand of pipettes. Micropipettes ... uL or less and are a great tool ... , The micropipette promotions were designed to ... alternative products to help customers find the right ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... has completed negotiations with Salem Realty Group and has ... and development space within the Salem Executive Complex adjacent ... cutting ceremony was held on Friday September 5th. Whitehouse ... to refit the entire space specifically for package testing. ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Oxides discovered by CCNY team could advance memory devices 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4
... JERSEY CITY, N.J., Jan. 18, 2011 Intrasphere ... consulting and solutions firm that provides services to ... become a Gold level member of Oracle PartnerNetwork ... Argus Safety Suite. As a result of this ...
... , This release is available in German ... chemist Professor Ralph G. Nuzzo paved the way for use ... imaginable today without that innovation. Professor Nuzzo is now honored ... The award includes guest visits to the Institute of Functional ...
... Cancer Research Foundation ("KCRF") announces research conducted in the ... Cancer Center has been published in the December 2010 ... Clinical Cancer Research journal.  The manuscript illustrates how ... prove that radiofrequency fields can treat pancreatic tumors, which ...
Cached Biology Technology:Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite 2Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite 3New impulses for surface research 2Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma 2
(Date:9/17/2014)... After decades of decline, grasses have returned to some ... the marsh in those places seems healthy again, but ... of the marsh coastal protection remains diminished. ... function hasn,t come back," said ecologist Mark Bertness, professor ... study in the journal Biological Conservation . "The ...
(Date:9/17/2014)... forms a new crime unit designed to fight food ... over horse meat being passed off as beef ... meat adulteration. They describe their approach, which represents a ... of Agricultural and Food Chemistry . , Hans-Ulrich Humpf ... global economic problem. But they also say that adding, ...
(Date:9/17/2014)... including MRSA and MSSA could be curbed by ... the scaly surface of shark skin, according to ... Antimicrobial Resistance and Infection Control . , The ... spread of human disease bacteria through touching, sneezes ... arrangement of ridges formulated to resemble shark skin. ...
Breaking Biology News(10 mins):Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3Sharks' skin has teeth in the fight against hospital superbugs 2
... saying goes: "Don,t judge a book by its cover." Well, ... dolphins are the most common and well-known of their kind ... dolphin might look similar to another, when you take a ... are differences. In fact, a recently published study in the ...
... Institute for Clinical Research, Inc., a company providing science-driven early ... appointment of Dan Bradbury , Managing Member of ... Board of Directors.  Mr. Bradbury joins Profil Institute,s current ... research executive and former Senior Vice President and Head ...
... cats really had nine lives, one reason might be to ... feline health. Yunjeong Kim, a research assistant professor in ... developed a research approach that tackles two deadly infectious feline ... by a $156,342 award from the Morris Animal Foundation. ...
Cached Biology News:Dolphin genetic study provides revelations 2Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors 2Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors 3College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 2College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases 3
... Kit is designed for concentration and ... samples. Proteomics sample analysis is often ... impurities such as buffers, salts and ... interfere with electrophoretic separations or enzymatic ...
... activated carrier proteins to simplify the ... Activated Carrier Proteins are commonly used ... a heterobifunctional cross-linker (Sulfo-SMCC). This activation ... protein. Thus allowing the maleimide-activated ...
... allows for rapid, convenient, and efficient native ... process utilizes a spin column to make ... concentration of proteins which were electro-eluted in ... ion exchangers, offering high binding capacity fo ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: